Worldwide News

Dotmatics’ eln.online is a quick start version of its Electronic Laboratory Notebook (ELN). Designed for research organisations at an early stage in their development, eln.online is a new version of the company’s existing ELN Studies Notebook. According to Dotmatics the software can be easily set up. It enables search and capture of experimental data in […]

Scenic Biotech has entered into a multi-year strategic collaboration with Genentech to discover, develop and commercialise novel therapeutics that target genetic modifiers. Genentech is a member of the Roche Group. Genetic modifiers are genes that counteract the effect of a disease-causing gene. They may explain why some people with genetic mutations linked to severe disease […]

Mogrify has won the AstraZeneca Life Science Innovation category of the Business Weekly Awards. The award commends Mogrify in applying its proprietary direct cellular conversion technology to further the cause of life science discovery for the benefit of human healthcare. Prof. Julian Gough, Co-founder and CSO of Mogrify, received the Cambridge Enterprise Academic Entrepreneur of […]

IDBS has released a fully-featured integration between the E-WorkBook electronic laboratory notebook (ELN) and SCIEX Analyst Software. This expands on IDBS’s existing family of integrations. This new integration aims to strengthen IDBS’ existing preclinical capabilities by seamlessly transferring data, enabling increased regulatory compliance and improved throughput. In response to the call for improved preclinical workflows […]

This webinar, hosted by DDW and presented by Sartorius, will examine T cell exhaustion and how it is recognised as a major challenge in the development of immuno-oncology therapies. A broad term used to describe the loss of effector function due to chronic antigen exposure, it commonly occurs within the tumour microenvironment, impairing the T […]

PCR Biosystems has launched RiboShield RNase Inhibitor. Already a component of several PCR Biosystems kits, this robust and reliable RNase inhibitor is now available as a standalone product. RiboShield RNase Inhibitor is a recombinant protein that blocks the activity of a range of ribonucleases to reliably protect RNA from RNase digestion. The inhibitor is designed for […]

Ensuring that pharmaceuticals are of the same quality during every individual production run is an essential regulatory requirement. To meet this, CombiGene and CGT Catapult have collaborated to develop a tailor-made package of analytical assays to ensure that the production of the AAV1 based gene therapy CG01 meets these regulatory requirements. CGT Catapult experts developed […]

Bio-Rad Laboratories has launched StarBright Violet 515 (SBV515) Dye. This is the first of a new range of fluorescent nanoparticles, for use in flow cytometry. StarBright Dyes are conjugated to a growing range of antibodies and are compatible with most flow cytometers and experimental protocols. The StarBright Violet 515 Dye with an excitation maximum at […]

This was first launched in 2017 as a comprehensive guide for live-cell analysis technologies, with a focus on the complete suite of Incucyte live-cell assays and reagents. The handbook has been well received by Incucyte users, generating over 2,500 requests of its third edition. The live-cell applications covered in the handbook include cell culture quality control assays […]

Optibrium has produced a peer-reviewed publication, Practical Applications of Deep Learning to Impute Heterogeneous Drug Discovery Data. It is in the Journal of Chemical Information and Modeling. It says this is testament to the unique ability of the Alchemite deep learning algorithm to extract additional value from experimental data in the context of an evolving drug […]

The Advanced Therapy Treatment Centre (ATTC) network has been awarded a total of £9.5 million to fund an additional 12 months of the programme. £6.5 million has been granted from the government’s Department for Business, Energy and Industrial Strategy (BEIS) and an additional £3 million from its Industrial Strategy Challenge Fund (ISCF), managed by UK […]

Lu Rahman looks at how opportunities are growing in Japanese drug development and where innovation is coming from. Japan is a fascinating drug discovery and development market. A strong pharmaceutical sector (some reports place it second globally behind the US), an ageing population and a tranche of expertise, put the country in a good position. […]

The event will take place online on 16 December 2020, 10:20 – 12:30 (GMT). The Pharmacology 2020 programme is live and ELRIG is inviting attendees to its symposium Beyond Potency: the pharmacology of safe & efficacious medicines. This will take place on 16 December 2020 from 10:20 – 12:30. For pharmacologists working in the pharma industry, the […]

Sanofi and GSK have started the Phase I/II clinical trial for their adjuvanted COVID-19 vaccine. The vaccine candidate, developed in partnership by Sanofi and GSK, uses the same recombinant protein-based technology as one of Sanofi’s seasonal influenza vaccines with GSK’s established pandemic adjuvant technology. The Phase I/II clinical trial is a randomised, double blind and […]

3 September 2020 Image: ThisisEngineering RAEng Researchers at the Cancer Research UK-AstraZeneca Antibody Alliance Laboratory in Cambridge, UK, have pioneered the development of an innovative affinity maturation technique. This generates an inhibitory, high-affinity antibody against Arginase 2 (ARG2), an enzyme implicated in major human diseases including cancer. Their findings are published in mAbs, following publication […]

A new international has shown that treating critically ill patients with COVID-19 with the steroid hydrocortisone improves their chances of recovery. The study, led in the UK by Professor Anthony Gordon from Imperial College London with collaborators from the Intensive Care National Audit & Research Centre, found that patients receiving intensive care who were treated […]